Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Immunotherapy is a promising new therapeutic approach for neuroblastoma (NBM): an anti-GD2 vaccine combined with orally administered soluble beta-glucan is undergoing a phase II clinical trial and nivolumab and ipilimumab are being tested in recurrent and refractory tumors. Unfortunately, predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardo, Salvo Danilo, Presti, Mario, Mangano, Katia, Petralia, Maria Cristina, Basile, Maria Sofia, Libra, Massimo, Candido, Saverio, Fagone, Paolo, Mazzon, Emanuela, Nicoletti, Ferdinando, Bramanti, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770763/
https://www.ncbi.nlm.nih.gov/pubmed/31480495
http://dx.doi.org/10.3390/brainsci9090221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770763/
https://www.ncbi.nlm.nih.gov/pubmed/31480495
http://dx.doi.org/10.3390/brainsci9090221

Ejemplares similares